2023

• Langbehn, D., Sathe, S., Loy, C., Sampaio, C., McCusker, E. (2023). A Phenotypic Atlas for Huntington Disease Based on Data From the Enroll-HD Cohort Study. Neurology: Genetics, 9(6), e200111. [More Information]
• Massey, S., Guo, Y., Riley, L., Van Bergen, N., Sandaradura, S., McCusker, E., Tchan, M., Thauvin-Robinet, C., Thomas, Q., Moreau, T., et al (2023). Expanding the Allelic Heterogeneity of ANO10-Associated Autosomal Recessive Cerebellar Ataxia. Neurology: Genetics, 9(1), e200051. [More Information]
• McCusker, E., Loy, C. (2023). Scientific, Ethical, and Practical Considerations for the Testing and Disclosure of Alzheimer Disease Biomarkers. Neurology, 100(21), 993-994. [More Information]

2022

• Waller, S., Williams, L., Lee, A., Lin, M., McCusker, E., Morales-Briceño, H., Fung, V. (2022). Isolated Craniocervical Dystonia Without Initial Neuropsychiatric Manifestations Associated with NMDA-Receptor Antibodies. Movement Disorders Clinical Practice, 10(4), 680-682. [More Information]

2021

• McCusker, E., Loy, C. (2021). Prevalent Nonmotor Symptoms Associated With Huntington Disease: Challenging to Interpret and With Early Impact on Function. Neurology, 96(19), 875-876. [More Information]

2019

• Masdeu, J., Aksamit, A., Carver, A., Foley, K., Kass, J., Martin, R., McCusker, E., McQuillen, M., Mehanna, R., Payne, R., et al (2019). End of life: Expert care and support, not physician-hastened death. Neurology, 93(17), 729-734. [More Information]
• Rojas, N., Ziliani, J., Cesarini, M., Etcheverry, J., da Prat, G., McCusker, E., Gatto, E. (2019). Late Onset Huntington Disease: Phenotypic and Genotypic Characteristics of 10 Cases in Argentina. Journal of Huntington's Disease, 8(2), 195-198. [More Information]
• Ross, C., Reilmann, R., Cardoso, F., McCusker, E., Testa, C., Stout, J., Leavitt, B., Pei, Z., Landwehrmeyer, B., Martinez, A., et al (2019). Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories. Movement Disorders Clinical Practice, 6(7), 541-546. [More Information]
• McGarry, A., McDermott, M., Kieburtz, K., Fung, W., McCusker, E., Peng, J., de Blieck, E., Cudkowicz, M. (2019). Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial. Neurology, 92(14), e1643-e1651. [More Information]

2017

• McGarry, A., McDermott, M., Kieburtz, K., de Blieck, E., Beal, F., Marder, K., Ross, C., Shoulson, I., Gilbert, P., Mallonee, W., McCusker, E., et al (2017). A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology, 88(2), 152-159. [More Information]
• McCusker, E., Loy, C. (2017). Huntington disease: The complexities of making and disclosing a clinical diagnosis after premanifest genetic testing. Tremor and other Hyperkinetic Movements, 7, 1-7. [More Information]
• McCusker, E., Loy, C. (2017). Medical management of motor manifestations of Huntington disease. Handbook of Clinical Neurology, 144, 141-150. [More Information]
• Chaganti, S., McCusker, E., Loy, C. (2017). What do we know about late onset Huntington's disease? Journal of Huntington's Disease, 6(2), 95-103. [More Information]

2016

• Epping, E., Kim, J., Craufurd, D., Brashers-Krug, T., Anderson, K., McCusker, E., Luther, J., Long, J., Paulsen, J. (2016). Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data. The American Journal of Psychiatry, 173(2), 184-192. [More Information]

2015

• Liu, D., Long, J., Zhang, Y., Raymond, L., Marder, K., Rosser, A., McCusker, E., Mills, J., Paulsen, J. (2015). Motor onset and diagnosis in Huntington disease using the diagnostic confidence level. Journal of Neurology, 262(12), 2691-2698. [More Information]
• Kim, J., Long, J., Mills, J., McCusker, E., Paulsen, J. (2015). Multivariate Clustering of Progression Profiles Reveals Different Depression Patterns in Prodromal Huntington Disease. Neuropsychology, 29(6), 949-960. [More Information]

2014

• Paulsen, J., Long, J., Johnson, H., Aylward, E., Ross, C., Williams, J., Nance, M., Erwin, C., Westervelt, H., Harrington, D., McCusker, E., et al (2014). Clinical and biomarker changes in premanifest huntington disease show trial feasibility: a decade of the PREDICT-HD study. Frontiers in Aging Neuroscience, 6, 1-11. [More Information]
• McCusker, E., Myers, R. (2014). Feasibility of Huntington disease trials in the disease prodrome. Neurology, 82(10), 824-825. [More Information]
• McCusker, E., Loy, C. (2014). The Many Facets of Unawareness in Huntington Disease. Tremor and other Hyperkinetic Movements, 4, 1-8. [More Information]

2013

• Paulsen, J., Nance, M., Kim, J., Carlozzi, N., Panegyres, P., Erwin, C., Goh, A., McCusker, E., Williams, J. (2013). A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Progress in Neurobiology, 110, 2-28. [More Information]
• Ramos, E., Latourelle, J., Gillis, T., Mysore, J., Squitieri, F., Di Pardo, A., Di Donato, S., Gellera, C., Hayden, M., Morrison, P., Trent, R., McCusker, E., et al (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173-179. [More Information]
• Loy, C., McCusker, E. (2013). Is a Motor Criterion Essential for the Diagnosis of Clinical Huntington Disease? PLoS Currents, 5, 1-9. [More Information]
• Biglan, K., Zhang, Y., Long, J., Geschwind, M., Kang, G., Killoran, A., Lu, W., McCusker, E., Mills, J., Raymond, L., et al (2013). Refining the diagnosis of Huntington disease: the PREDICT-HD study. Frontiers in Aging Neuroscience, 5(April 2013), 1-8. [More Information]
• Aylward, E., Harrington, D., Mills, J., Nopoulos, P., Ross, C., Long, J., Liu, D., Westervelt, H., Paulsen, J., Cross, S., et al (2013). Regional atrophy associated with cognitive and motor function in prodromal huntington disease. Journal of Huntington's Disease, 2(4), 477-489. [More Information]
• McCusker, E., Gunn, D., Epping, E., Loy, C., Radford, K., Griffith, J., Mills, J., Long, J., Paulsen, J. (2013). Unawareness of motor phenoconversion in Huntington disease. Neurology, 81(13), 1141-1147. [More Information]

2012

• Lee, J., Ramos, E., Lee, J., Gillis, T., Mysore, J., Hayden, M., Warby, S., Morrison, P., Nance, M., Ross, C., Trent, R., McCusker, E., et al (2012). CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology, 78(10), 690-695. [More Information]
• Ramos, E., Latourelle, J., Lee, J., Gillis, T., Mysore, J., Squitieri, F., Di Pardo, A., Di Donato, S., Hayden, M., Morrison, P., Trent, R., McCusker, E., et al (2012). Population stratification may bias analysis of PGC-1(alpha) as a modifier of age at Huntington disease motor onset. Human Genetics, 131(12), 1833-1840. [More Information]
• Lee, J., Lee, J., Ramos, E., Gillis, T., Mysore, J., Kishikawa, S., Hadzi, T., Hendricks, A., Hayden, M., Morrison, P., Trent, R., McCusker, E., et al (2012). TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications, 424(3), 404-408. [More Information]

2010

• Gabery, S., Murphy, K., Schultz, K., Loy, C., McCusker, E., Kirik, D., Halliday, G., Petersen, A. (2010). Changes in Key Hypothalamic Neuropeptide Populations in Huntington Disease Revealed by Neuropathological Analyses. Acta Neophilologica, 120, 777-788. [More Information]

2006

• Li, J., Hayden, M., Warby, S., Durr, A., Morrison, P., Nance, M., Ross, C., Margolis, R., Rosenblatt, A., Trent, R., McCusker, E., et al (2006). Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. BMC Medical Genetics, 7, 71-71. [More Information]

2005

• Kipps, C., Duggins, A., Mahant, N., Gomes, L., Ashburner, J., McCusker, E. (2005). Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. Journal of Neurology, Neurosurgery and Psychiatry, 76(5), 650-5. [More Information]

2003

• Mahant, N., McCusker, E., Byth Wilson, K., Graham, S., The Huntington Study Group. (2003). Huntington's disease: Clinical correlates of disability and progression. Neurology, 61(8), 1085-1092. [More Information]

2002

• Thieben, M., Duggins, A., Good, C., Gomes, L., Mahant, N., Richards, F., McCusker, E., Frackowiak, R. (2002). The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain, 125(8), 1815-1828. [More Information]

2000

• McCusker, E., Richards, F., Sillence, D., Wilson, M., Trent, R. (2000). Huntington's disease: neurological assessment of potential gene carriers presenting for predictive DNA testing. Journal of Clinical Neuroscience.